Summary & Overview
HCPCS G8490: Intent to Report Rheumatoid Arthritis Measures
HCPCS Level II code G8490 designates a provider’s intent to report the rheumatoid arthritis (RA) measures group for quality and performance reporting. As a quality-reporting code rather than a direct clinical service, G8490 signals participation in RA-related measure collection and may be used in administrative and claims-based reporting workflows across ambulatory rheumatology and specialty care practices. Nationally, such codes matter because they structure how quality data are captured, enable payer performance tracking, and inform value-based payment and public reporting initiatives.
Key payers in national reporting contexts include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find benchmarks and context about measure reporting use cases, the clinical environment where the code is applied, and policy-level considerations impacting RA measure submission. The publication covers: definitions and clinical context for RA measure reporting; payer participation and expectations; typical sites and workflows for submitting the code; and implications for quality programs and reporting pipelines. Data not available in the input is noted where specific payer policies, modifiers, taxonomies, ICD-10 pairings, and related codes would normally be detailed.
Billing Code Overview
HCPCS Level II code G8490 indicates intent to report the rheumatoid arthritis (ra) measures group. This code is used to denote that a provider or reporting entity intends to submit data for performance measures related to rheumatoid arthritis.
-
Service type: Quality reporting/measure reporting activity
-
Typical site of service: Administrative/clinical reporting workflows across ambulatory and specialty rheumatology settings
Clinical & Coding Specifications
Clinical Context
A 58-year-old female with established rheumatoid arthritis presents to a rheumatology clinic for annual quality-measure reporting and care-plan review. The clinician documents current disease activity, verifies the medication list including disease-modifying antirheumatic drugs (DMARDs), reviews vaccination status, screens for disease complications, and confirms functional status and shared decision-making about treatment options. The office visit includes chart abstraction and reporting steps required to attest to participation in the rheumatoid arthritis measures group represented by G8490. Typical workflow: initial nurse intake collects vitals and patient-reported outcomes (pain score, HAQ or RAPID3), clinician performs focused musculoskeletal exam, updates medication list and adverse events, documents disease activity and treatment plan in the EHR, and clinical staff complete measure-specific data elements and submit the group reporting attestation to the payer or quality program.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a distinct E/M visit is billed the same day as a procedure or service related to RA reporting. |
59 | Distinct procedural service | Use to indicate a distinct service or procedure not normally reported together with another service on the same day.